...

Module

Interferon and Ribavirin: Mechanisms of Action, Resistance, and Why It Matters

Source: Hepatitis Annual Update 2006

Interferon and Ribavirin: Mechanisms of Action, Resistance, and Why It Matters


CME Program Director: Emmet B. Keeffe, MD, MACP

Faculty:

Raymond T. Chung, MD
  • Raymond T. Chung, MD

CREDIT INFORMATION

Release Date: August 03, 2006

Expiration Date: August 02, 2007


Physicians: maximum of 1.25 AMA PRA Category 1 Credits

Registered Nurses: 1.6 Nursing contact hours

Pharmacists: 1.3 contact hours (0.13 CEUs)

Status: The activity is not currently available for credit.


Begin the Module

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Describe the epidemiology, natural history, and life cycle of hepatitis C virus (HCV)
  • Review mechanisms of current approaches for the treatment of HCV
  • Recount the rationale and potential for novel agents in the treatment of HCV

Topics covered include:

  • Epidemiology and Natural History of Hepatitis C Virus (HCV)
  • Resistance to Interferon and Ribavirin
  • Viral Kinetics of HCV
  • Mechanisms of Action of Antiviral Agents: Interferon
  • Mechanisms of Action of Antiviral Agents: Ribavirin
  • Impact of Current Agents’ Characteristics on Selection of Future Antiviral Therapy
  • The Virus Fights Back: HCV Subversion of Antiviral Defenses
  • Therapeutic Strategies for Circumventing Viral Roadblocks: Innate Immunity
  • Future Contenders in Anti-HCV Therapy
  • Summary—Implications for Clinical Practice


Disclaimer: The materials published on the Clinical Care Options Sites reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.

Jointly sponsored by Postgraduate Institute for Medicine and Clinical Care Options, LLC.

Contact Info

Educational grants provided by:

Educational grants support only the CME-certified components of this program.